Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-16-005275
Filing Date
2016-05-04
Accepted
2016-05-04 13:30:14
Documents
51
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tlog-20160331x10q.htm 10-Q 1192833
2 EX-31.1 tlog-20160331ex3111eafc5.htm EX-31.1 18279
3 EX-31.2 tlog-20160331ex312113dc8.htm EX-31.2 18321
4 EX-32.1 tlog-20160331ex321f4f18a.htm EX-32.1 7741
5 EX-32.2 tlog-20160331ex322a24a40.htm EX-32.2 7563
  Complete submission text file 0001558370-16-005275.txt   5643918

Data Files

Seq Description Document Type Size
6 EX-101.INS tlog-20160331.xml EX-101.INS 1326981
7 EX-101.SCH tlog-20160331.xsd EX-101.SCH 37229
8 EX-101.CAL tlog-20160331_cal.xml EX-101.CAL 47440
9 EX-101.DEF tlog-20160331_def.xml EX-101.DEF 152190
10 EX-101.LAB tlog-20160331_lab.xml EX-101.LAB 412369
11 EX-101.PRE tlog-20160331_pre.xml EX-101.PRE 273496
Mailing Address 343 PHOENIXVILLE PIKE MALVERN PA 19355
Business Address 343 PHOENIXVILLE PIKE MALVERN PA 19355 610-889-9900
TETRALOGIC PHARMACEUTICALS CORP (Filer) CIK: 0001361248 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36208 | Film No.: 161618504
SIC: 2834 Pharmaceutical Preparations